The Drug Chemical & Associated Technologies Association – Trademark Portfolio
Entity Type: 03
The Drug Chemical & Associated Technologies Association holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include DCAT WEEK and DCAT DRUG, CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION. The owner is based in Robbinsville, NJ.
One Union Street, Suite 208
Robbinsville, NJ 08691
Showing of trademarks Trademarks
Trademark Classifications
The Drug Chemical & Associated Technologies Association's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does The Drug Chemical & Associated Technologies Association have?
The Drug Chemical & Associated Technologies Association has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does The Drug Chemical & Associated Technologies Association file in?
The Drug Chemical & Associated Technologies Association files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.
What are The Drug Chemical & Associated Technologies Association's most well-known trademarks?
The Drug Chemical & Associated Technologies Association's registered trademark portfolio includes well-known marks such as DCAT WEEK and DCAT DRUG, CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION. These are among 2 currently registered trademarks in the portfolio.
What is The Drug Chemical & Associated Technologies Association's trademark registration success rate?
The Drug Chemical & Associated Technologies Association has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.